Ding-Cheng Derrick Chan1,2,3, Lo-Yu Chang4, Kristina E Akesson5,6, Paul Mitchell7,8,9, Chung-Hwan Chen10,11,12,13, E Michael Lewiecki14, Joon Kiong Lee15, Tang Ching Lau16,17, Thawee Songpatanasilp18, Kin Bong Lee19, Kwang Joon Kim20,21, Jung-Fu Chen22, Ko-En Huang23, Yih-Lan Gau24, Yin-Fan Chang25, Peter Ebeling26,27,28, Weibo Xia29, Wei Yu30, Atsushi Suzuki31, Fen Lee Hew32, Leilani B Mercado-Asis33, Yoon-Sok Chung34, Keh-Sung Tsai2,35, Gau-Tyan Lin36, Rong-Sen Yang37, Chih-Hsing Wu38,39. 1. Department of Geriatrics and Gerontology, National Taiwan University Hospital, Taipei, Taiwan. 2. Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. 3. Superintendent Office, Chutung Branch, National Taiwan University Hospital, Hsinchu County, Taiwan. 4. School of Medicine, National Taiwan University, Taipei, Taiwan. 5. Department of Clinical Sciences, Lund University, Malmö, Sweden. 6. Department of Orthopedics, Skåne University Hospital, Malmö, Sweden. 7. Synthesis Medical NZ Ltd, Auckland, New Zealand. 8. University of Notre Dame Australia, Sydney, Australia. 9. Osteoporosis New Zealand, Wellington, New Zealand. 10. Orthopaedic Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. 11. Department of Orthopaedics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. 12. Department of Orthopaedics, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. 13. Department of Orthopaedics, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. 14. New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA. 15. Beacon Hospital, Petaling Jaya, Selangor, Malaysia. 16. Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. 17. Department of University Medicine Cluster, National University Health System, Singapore, Singapore. 18. Department of Orthopaedics, Phramongkutklao Hospital, Bangkok, Thailand. 19. Department of Orthopaedics and Traumatology, Queen Elizabeth Hospital, Kowloon, Hong Kong. 20. Division of Geriatrics, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea. 21. Executive Health Promotion Center, Gangnam Severance Hospital, Executive Health Promotion Center, Gangnam Severance Hospital Yonsei University Health System, Seoul, Republic of Korea. 22. Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan. 23. Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan City, Taiwan. 24. Department of Orthopaedics, Taitung Christian Hospital, Taitung, Taiwan. 25. Department of Family Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, No. 138, Sheng Li Road, Tainan, 70428, Taiwan. 26. Bone and Muscle Health Research Group, Department of Medicine, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia. 27. Melbourne Medical School (Western Campus), University of Melbourne, St Albans, Australia. 28. Australian Institute for Musculoskeletal Science, St Albans, Australia. 29. Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China. 30. Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China. 31. Division of Endocrinology and Metabolism, Department of Internal Medicine, Fujita Health University, Toyoake, Aichi, Japan. 32. Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia. 33. University of Santo Tomas, Manila City, Philippines. 34. Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Republic of Korea. 35. Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan. 36. Department of Orthopedic Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. 37. Department of Orthopedics, National Taiwan University Hospital, Room 11-17, Research Build, No7, Chungshan S. Rd., Taipei, Taiwan. rsy0819@gmail.com. 38. Department of Family Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, No. 138, Sheng Li Road, Tainan, 70428, Taiwan. paulo@mail.ncku.edu.tw. 39. Institute of Gerontology, College of Medicine, National Cheng Kung University, No.1, University Road, Tainan, Taiwan. paulo@mail.ncku.edu.tw.
Abstract
The Fracture Liaison Service (FLS) Consensus Meeting endorsed by the International Osteoporosis Foundation (IOF), Asian Federation of Osteoporosis Societies (AFOS), and Asia Pacific Osteoporosis Foundation (APOF) was hosted by the Taiwanese Osteoporosis Association on October 14, 2017. International and domestic experts reviewed the 13 Best Practice Framework (BPF) standards and concluded that all standards were generally applicable in the Asia-Pacific region and needed only minor modifications to fit the healthcare settings in the region. PURPOSE: To review and generate consensus on best practices of fracture liaison service (FLS) in the Asia-Pacific (AP) region. METHODS: In October 2017, the Taiwanese Osteoporosis Association (TOA) invited experts from the AP region (n = 23), the Capture the Fracture Steering Committee (n = 2), and the USA (n = 1) to join the AP region FLS Consensus Meeting in Taipei. After two rounds of consensus generation, the recommendations on the 13 Best Practice Framework (BPF) standards were reported and reviewed by the attendees. Experts unable to attend the on-site meeting reviewed the draft, made suggestions, and approved the final version. RESULTS: Because the number of FLSs in the region is rapidly increasing, experts agreed that it was timely to establish consensus on benchmark quality standards for FLSs in the region. They also agreed that the 13 BPF standards and the 3 levels of standards were generally applicable, but that some clarifications were necessary. They suggested, for example, that patient and family education be incorporated into the current standards and that communication with the public to promote FLSs be increased. CONCLUSIONS: The consensus on the 13 BPF standards reviewed in this meeting was that they were generally applicable and required only a few advanced clarifications to increase the quality of FLSs in the region.
The Fracture Liaison Service (FLS) Consensus Meeting endorsed by the International Osteoporosis Foundation (IOF), Asian Federation of Osteoporosis Societies (AFOS), and Asia Pacific Osteoporosis Foundation (APOF) was hosted by the Taiwanese Osteoporosis Association on October 14, 2017. International and domestic experts reviewed the 13 Best Practice Framework (BPF) standards and concluded that all standards were generally applicable in the Asia-Pacific region and needed only minor modifications to fit the healthcare settings in the region. PURPOSE: To review and generate consensus on best practices of fracture liaison service (FLS) in the Asia-Pacific (AP) region. METHODS: In October 2017, the Taiwanese Osteoporosis Association (TOA) invited experts from the AP region (n = 23), the Capture the Fracture Steering Committee (n = 2), and the USA (n = 1) to join the AP region FLS Consensus Meeting in Taipei. After two rounds of consensus generation, the recommendations on the 13 Best Practice Framework (BPF) standards were reported and reviewed by the attendees. Experts unable to attend the on-site meeting reviewed the draft, made suggestions, and approved the final version. RESULTS: Because the number of FLSs in the region is rapidly increasing, experts agreed that it was timely to establish consensus on benchmark quality standards for FLSs in the region. They also agreed that the 13 BPF standards and the 3 levels of standards were generally applicable, but that some clarifications were necessary. They suggested, for example, that patient and family education be incorporated into the current standards and that communication with the public to promote FLSs be increased. CONCLUSIONS: The consensus on the 13 BPF standards reviewed in this meeting was that they were generally applicable and required only a few advanced clarifications to increase the quality of FLSs in the region.
Entities:
Keywords:
Case management; Fragility; Osteoporosis; Re-fracture; Secondary prevention
Authors: P R Ebeling; D-C Chan; T C Lau; J K Lee; T Songpatanasilp; S H Wong; F L Hew; R Sethi; M Williams Journal: Osteoporos Int Date: 2019-12-01 Impact factor: 4.507
Authors: M Chandran; P J Mitchell; T Amphansap; S K Bhadada; M Chadha; D-C Chan; Y-S Chung; P Ebeling; N Gilchrist; A Habib Khan; P Halbout; F L Hew; H-P T Lan; T C Lau; J K Lee; S Lekamwasam; G Lyubomirsky; L B Mercado-Asis; A Mithal; T V Nguyen; D Pandey; I R Reid; A Suzuki; T T Chit; K L Tiu; T Valleenukul; C K Yung; Y L Zhao Journal: Osteoporos Int Date: 2021-01-27 Impact factor: 4.507
Authors: A Naranjo; S Ojeda; M Giner; M Balcells-Oliver; L Canals; J M Cancio; E Duaso; J Mora-Fernández; C Pablos; A González; B Lladó; F J Olmo; M J Montoya; A Menéndez; D Prieto-Alhambra Journal: Arch Osteoporos Date: 2020-04-25 Impact factor: 2.617